Showing 1 - 18 results of 18 for search 'Ingrid Simonitsch-Klupp', query time: 0.05s Refine Results
  1. 1
    Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

    Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma by Barbara Kiesewetter, Ingrid Simonitsch-Klupp, Werner Dolak, Marius E. Mayerhoefer, Markus Raderer

    Published 2020-02-01
    Get full text
    Article
  2. 2
    First Line Systemic Treatment for MALT Lymphoma—Do We Still Need Chemotherapy? Real World Data from the Medical University Vienna

    First Line Systemic Treatment for MALT Lymphoma—Do We Still Need Chemotherapy? Real World Data from the Medical University Vienna by Barbara Kiesewetter, Ingrid Simonitsch-Klupp, Marius E. Mayerhoefer, Werner Dolak, Julius Lukas, Markus Raderer

    Published 2020-11-01
    Get full text
    Article
  3. 3
    Anaplasmataceae-Specific PCR for Diagnosis and Therapeutic Guidance for Symptomatic Neoehrlichiosis in Immunocompetent Host

    Anaplasmataceae-Specific PCR for Diagnosis and Therapeutic Guidance for Symptomatic Neoehrlichiosis in Immunocompetent Host by Michael Schwameis, Julia Auer, Dieter Mitteregger, Ingrid Simonitsch-Klupp, Michael Ramharter, Heinz Burgmann, Heimo Lagler

    Published 2016-02-01
    Get full text
    Article
  4. 4
    Teduglutide in amyloidosis‐associated intestinal failure

    Teduglutide in amyloidosis‐associated intestinal failure by Clara Luhn, Hermine Agis, Elisabeth Hütterer, Ingrid Simonitsch‐Klupp, Christopher Dawoud, Anton Stift, Felix Harpain

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Overexpression of the transcriptional repressor complex BCL-6/BCoR leads to nuclear aggregates distinct from classical aggresomes.

    Overexpression of the transcriptional repressor complex BCL-6/BCoR leads to nuclear aggregates distinct from classical aggresomes. by Elisabeth Buchberger, Miriam El Harchi, Dietmar Payrhuber, Anna Zommer, Dominic Schauer, Ingrid Simonitsch-Klupp, Martin Bilban, Christine Brostjan

    Published 2013-01-01
    Get full text
    Article
  6. 6
    Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.

    Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging. by Ulrika Asenbaum, Richard Nolz, Georgios Karanikas, Julia Furtner, Ramona Woitek, Anton Staudenherz, Daniela Senn, Markus Raderer, Michael Weber, Ingrid Simonitsch-Klupp, Marius E Mayerhoefer

    Published 2016-01-01
    Get full text
    Article
  7. 7
    Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis

    Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis by Klaus Geissler, Bettina Gisslinger, Eva Jäger, Roland Jäger, Ana-Iris Schiefer, Edith Bogner, Elisabeth Fuchs, Fiorella Schischlik, Donat Alpar, Ingrid Simonitsch-Klupp, Robert Kralovics, Heinz Gisslinger

    Published 2020-08-01
    Get full text
    Article
  8. 8
    Influence of <i>TP53</i> Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era

    Influence of <i>TP53</i> Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era by Edit Porpaczy, Philipp Wohlfarth, Oliver Königsbrügge, Werner Rabitsch, Cathrin Skrabs, Philipp Staber, Nina Worel, Leonhard Müllauer, Ingrid Simonitsch-Klupp, Christoph Kornauth, Johannes Rohrbeck, Ulrich Jaeger, Ana-Iris Schiefer

    Published 2021-11-01
    Get full text
    Article
  9. 9
    PD‐L1 and PD1 expression in post‐transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter‐ and intra‐individual descriptive study covering the whole spectrum of PTLD categories

    PD‐L1 and PD1 expression in post‐transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter‐ and intra‐individual descriptive study covering the whol... by Ana‐Iris Schiefer, Elisabeth Salzer, Anna Füreder, Zsolt Szepfalusi, Thomas Müller‐Sacherer, Wolf‐Dietrich Huber, Ina Michel‐Behnke, Anita Lawitschka, Herbert Pichler, Georg Mann, Caroline Hutter, Ingrid Simonitsch‐Klupp, Andishe Attarbaschi

    Published 2019-08-01
    Get full text
    Article
  10. 10
    Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling

    Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling by Melanie R. Hassler, Walter Pulverer, Ranjani Lakshminarasimhan, Elisa Redl, Julia Hacker, Gavin D. Garland, Olaf Merkel, Ana-Iris Schiefer, Ingrid Simonitsch-Klupp, Lukas Kenner, Daniel J. Weisenberger, Andreas Weinhaeusel, Suzanne D. Turner, Gerda Egger

    Published 2016-10-01
    Get full text
    Article
  11. 11
    Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria

    Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria by Anna Füreder, Gabriele Kropshofer, Martin Benesch, Michael Dworzak, Sabine Greil, Wolf‐Dietrich Huber, Holger Hubmann, Anita Lawitschka, Georg Mann, Ina Michel‐Behnke, Thomas Müller‐Sacherer, Herbert Pichler, Ingrid Simonitsch‐Klupp, Wolfgang Schwinger, Zsolt Szepfalusi, Roman Crazzolara, Andishe Attarbaschi, Austrian Society of Pediatric Hematology and Oncology

    Published 2021-10-01
    Get full text
    Article
  12. 12
    Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study

    Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study by Ulrich Jaeger, Ulrich Jaeger, Ingrid Simonitsch-Klupp, Patrick Klammer, Alexander Egle, Sonja Heibl, Peter Neumeister, Ella Willenbacher, Florian Erlsbacher, Julian Larcher-Senn, Philipp B. Staber, Edit Porpaczy, Cathrin Skrabs, Marius E. Mayerhoefer, Marius E. Mayerhoefer, Marcus Hacker, Thomas Melchardt, Michael A. Fridrik, Richard Greil, Richard Greil

    Published 2024-03-01
    Get full text
    Article
  13. 13
    Genetic Characterization and Clinical Features of <i>Helicobacter pylori</i> Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

    Genetic Characterization and Clinical Features of <i>Helicobacter pylori</i> Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Barbara Kiesewetter, Christiane Copie-Bergman, Michael Levy, Fangtian Wu, Jehan Dupuis, Caroline Barau, Luca Arcaini, Marco Paulli, Marco Lucioni, Arturo Bonometti, Antonio Salar, Concepción Fernández-Rodriguez, Miguel A. Piris, Francesco Cucco, Rachel Dobson, Yan Li, Zi Chen, Cyrielle Robe, Ingrid Simonitsch-Klupp, Andrew Wotherspoon, Markus Raderer, Ming Qing Du

    Published 2021-06-01
    Get full text
    Article
  14. 14
    The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma

    The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma by Nina Worel, Katharina Grabmeier-Pfistershammer, Bernhard Kratzer, Martina Schlager, Andreas Tanzmann, Arno Rottal, Ulrike Körmöczi, Edit Porpaczy, Philipp B. Staber, Cathrin Skrabs, Harald Herkner, Venugopal Gudipati, Johannes B. Huppa, Benjamin Salzer, Manfred Lehner, Nora Saxenhuber, Eleonora Friedberg, Philipp Wohlfarth, Georg Hopfinger, Werner Rabitsch, Ingrid Simonitsch-Klupp, Ulrich Jäger, Winfried F. Pickl

    Published 2023-01-01
    Get full text
    Article
  15. 15
    The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies

    The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies by Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, Elisabeth L. Zeilinger, Andras Acel, Olivera Cenic, Andrea Schrott, Matthias Unseld, Anahita Paula Rassoulian, Cathrin Skrabs, Peter Valent, Heinz Gisslinger, Christine Marosi, Matthias Preusser, Gerald Prager, Gabriela Kornek, Robert Pirker, Günther G. Steger, Rupert Bartsch, Markus Raderer, Ingrid Simonitsch‐Klupp, Renate Thalhammer, Christoph Zielinski, Ulrich Jäger

    Published 2022-09-01
    Get full text
    Article
  16. 16
    Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease

    Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease by Ellen Gelpi, Simone Baiardi, Carlos Nos, Sofia Dellavalle, Iban Aldecoa, Raquel Ruiz-Garcia, Lourdes Ispierto, Domingo Escudero, Virgina Casado, Elena Barranco, Anuncia Boltes, Laura Molina-Porcel, Nuria Bargalló, Marcello Rossi, Angela Mammana, Dorina Tiple, Luana Vaianella, Elisabeth Stoegmann, Ingrid Simonitsch-Klupp, Gregor Kasprian, Sigrid Klotz, Romana Höftberger, Herbert Budka, Gabor G. Kovacs, Isidre Ferrer, Sabina Capellari, Raquel Sanchez-Valle, Piero Parchi

    Published 2022-08-01
    Get full text
    Article
  17. 17
    Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma

    Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma by Huan-Chang Liang, Mariantonia Costanza, Nicole Prutsch, Mark W. Zimmerman, Elisabeth Gurnhofer, Ivonne A. Montes-Mojarro, Brian J. Abraham, Nina Prokoph, Stefan Stoiber, Simone Tangermann, Cosimo Lobello, Jan Oppelt, Ioannis Anagnostopoulos, Thomas Hielscher, Shahid Pervez, Wolfram Klapper, Francesca Zammarchi, Daniel-Adriano Silva, K. Christopher Garcia, David Baker, Martin Janz, Nikolai Schleussner, Falko Fend, Šárka Pospíšilová, Andrea Janiková, Jacqueline Wallwitz, Dagmar Stoiber, Ingrid Simonitsch-Klupp, Lorenzo Cerroni, Stefano Pileri, Laurence de Leval, David Sibon, Virginie Fataccioli, Philippe Gaulard, Chalid Assaf, Fabian Knörr, Christine Damm-Welk, Wilhelm Woessmann, Suzanne D. Turner, A. Thomas Look, Stephan Mathas, Lukas Kenner, Olaf Merkel

    Published 2021-09-01
    Get full text
    Article
  18. 18
    Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence

    Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence by Ellen Gelpi, Sigrid Klotz, Miriam Beyerle, Sven Wischnewski, Verena Harter, Harald Kirschner, Katharina Stolz, Christoph Reisinger, Elisabeth Lindeck-Pozza, Alexander Zoufaly, Marlene Leoni, Gregor Gorkiewicz, Martin Zacharias, Christine Haberler, Johannes Hainfellner, Adelheid Woehrer, Simon Hametner, Thomas Roetzer, Till Voigtländer, Gerda Ricken, Verena Endmayr, Carmen Haider, Judith Ludwig, Andrea Polt, Gloria Wilk, Susanne Schmid, Irene Erben, Anita Nguyen, Susanna Lang, Ingrid Simonitsch-Klupp, Christoph Kornauth, Maja Nackenhorst, Johannes Kläger, Renate Kain, Andreas Chott, Richard Wasicky, Robert Krause, Günter Weiss, Judith Löffler-Rag, Thomas Berger, Patrizia Moser, Afshin Soleiman, Martin Asslaber, Roland Sedivy, Nikolaus Klupp, Martin Klimpfinger, Daniele Risser, Herbert Budka, Lucas Schirmer, Anne-Katrin Pröbstel, Romana Höftberger

    Published 2023-03-01
    Get full text
    Article

Search Tools: